Dr. Lal PathLabs Receives NCLT Approval for Voluntary Liquidation of Suburban Diagnostics Subsidiary
Published on: March 10, 2026, 3:44 p.m. | Source: scanx.trade
Dr. Lal PathLabs Limited has successfully completed the voluntary liquidation of its wholly owned subsidiary Suburban Diagnostics (India) Private Limited, receiving NCLT Mumbai Bench approval on February 27, 2026. The subsidiary, which contributed INR 164.03 crores in turnover and INR 126.62 crores in net worth as of March 31, 2024, had its business operations consolidated with the parent company on March 18, 2025. The liquidation process, initiated with board approval in February 2025, was conducted under the Insolvency and Bankruptcy Code with all stakeholder claims settled and regulatory compliance maintained.
